(ARES) Ares Management - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US03990B1017
Stock: Lending, Investments, Real Estate, Management
Total Rating 28
Risk 60
Buy Signal -0.76
| Risk 5d forecast | |
|---|---|
| Volatility | 45.6% |
| Relative Tail Risk | 2.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.49 |
| Alpha | -57.53 |
| Character TTM | |
|---|---|
| Beta | 1.647 |
| Beta Downside | 1.586 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.65% |
| CAGR/Max DD | 0.37 |
EPS (Earnings per Share)
Revenue
Description: ARES Ares Management March 04, 2026
Ares Management Corporation (ARES) is an alternative asset manager. It operates across the United States, Europe, and Asia.
The firms Direct Lending Group provides financing to small-to-medium sized businesses, a common practice in private credit markets. Its Private Equity Group focuses on control investments in under-capitalized companies. The Real Estate Group invests in developments and asset repositioning, and originates financing for middle-market commercial real estate, a sector often characterized by illiquid assets.
Ares targets investments between $1 million and $400 million. It seeks companies with EBITDA between $10 million and $250 million and debt investments valued between $10 million and $100 million. Founded in 1997, Ares is headquartered in Los Angeles, California.
For more detailed financial analysis of Ares Management, ValueRay offers comprehensive data and insights.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 527.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -5.52 > 1.0 |
| NWC/Revenue: 31.63% < 20% (prev -2.21%; Δ 33.83% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.62b > Net Income 527.4m |
| Net Debt (13.41b) to EBITDA (2.18b): 6.14 < 3 |
| Current Ratio: 2.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (221.1m) vs 12m ago 2.82% < -2% |
| Gross Margin: 58.32% > 18% (prev 0.55%; Δ 5776 % > 0.5%) |
| Asset Turnover: 21.76% > 50% (prev 15.61%; Δ 6.15% > 0%) |
| Interest Coverage Ratio: 2.35 > 6 (EBITDA TTM 2.18b / Interest Expense TTM 767.5m) |
Altman Z'' 0.63
| A: 0.06 (Total Current Assets 3.35b - Total Current Liabilities 1.49b) / Total Assets 28.99b |
| B: -0.05 (Retained Earnings -1.45b / Total Assets 28.99b) |
| C: 0.07 (EBIT TTM 1.80b / Avg Total Assets 26.94b) |
| D: -0.07 (Book Value of Equity -1.43b / Total Liabilities 20.29b) |
| Altman-Z'' Score: 0.63 = B |
Beneish M -2.83
| DSRI: 0.83 (Receivables 1.90b/1.51b, Revenue 5.86b/3.88b) |
| GMI: 0.95 (GM 58.32% / 55.42%) |
| AQI: 1.08 (AQ_t 0.87 / AQ_t-1 0.80) |
| SGI: 1.51 (Revenue 5.86b / 3.88b) |
| TATA: -0.04 (NI 527.4m - CFO 1.62b) / TA 28.99b) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
What is the price of ARES shares?
As of March 05, 2026, the stock is trading at USD 116.21 with a total of 2,949,196 shares traded.
Over the past week, the price has changed by -2.49%, over one month by -15.31%, over three months by -27.92% and over the past year by -25.46%.
Over the past week, the price has changed by -2.49%, over one month by -15.31%, over three months by -27.92% and over the past year by -25.46%.
Is ARES a buy, sell or hold?
Ares Management has received a consensus analysts rating of 3.93.
Therefore, it is recommended to buy ARES.
- StrongBuy: 4
- Buy: 6
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ARES price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 170.6 | 46.8% |
| Analysts Target Price | 170.6 | 46.8% |
ARES Fundamental Data Overview March 05, 2026
P/E Trailing = 65.8772
P/E Forward = 17.301
P/S = 6.5888
P/B = 8.2893
P/EG = 0.816
Revenue TTM = 5.86b USD
EBIT TTM = 1.80b USD
EBITDA TTM = 2.18b USD
Long Term Debt = 11.26b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.49b USD (from shortTermDebt, last quarter)
Debt = 14.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.41b USD (from netDebt column, last quarter)
Enterprise Value = 50.32b USD (36.91b + Debt 14.91b - CCE 1.50b)
Interest Coverage Ratio = 2.35 (Ebit TTM 1.80b / Interest Expense TTM 767.5m)
EV/FCF = 32.58x (Enterprise Value 50.32b / FCF TTM 1.54b)
FCF Yield = 3.07% (FCF TTM 1.54b / Enterprise Value 50.32b)
FCF Margin = 26.34% (FCF TTM 1.54b / Revenue TTM 5.86b)
Net Margin = 9.00% (Net Income TTM 527.4m / Revenue TTM 5.86b)
Gross Margin = 58.32% ((Revenue TTM 5.86b - Cost of Revenue TTM 2.44b) / Revenue TTM)
Gross Margin QoQ = 72.65% (prev 60.19%)
Tobins Q-Ratio = 1.74 (Enterprise Value 50.32b / Total Assets 28.99b)
Interest Expense / Debt = 1.25% (Interest Expense 186.1m / Debt 14.91b)
Taxrate = 3.94% (8.15m / 206.6m)
NOPAT = 1.73b (EBIT 1.80b * (1 - 3.94%))
Current Ratio = 2.24 (Total Current Assets 3.35b / Total Current Liabilities 1.49b)
Debt / Equity = 3.49 (Debt 14.91b / totalStockholderEquity, last quarter 4.28b)
Debt / EBITDA = 6.14 (Net Debt 13.41b / EBITDA 2.18b)
Debt / FCF = 8.68 (Net Debt 13.41b / FCF TTM 1.54b)
Total Stockholder Equity = 4.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.96% (Net Income 527.4m / Total Assets 28.99b)
RoE = 12.01% (Net Income TTM 527.4m / Total Stockholder Equity 4.39b)
RoCE = 11.51% (EBIT 1.80b / Capital Employed (Equity 4.39b + L.T.Debt 11.26b))
RoIC = 11.19% (NOPAT 1.73b / Invested Capital 15.47b)
WACC = 8.88% (E(36.91b)/V(51.82b) * Re(11.98%) + D(14.91b)/V(51.82b) * Rd(1.25%) * (1-Tc(0.04)))
Discount Rate = 11.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.95%
[DCF] Terminal Value 66.34% ; FCFF base≈2.01b ; Y1≈1.32b ; Y5≈601.0m
[DCF] Fair Price = N/A (negative equity: EV 10.19b - Net Debt 13.41b = -3.22b; debt exceeds intrinsic value)
EPS Correlation: 74.07 | EPS CAGR: 23.86% | SUE: -2.74 | # QB: 0
Revenue Correlation: 80.65 | Revenue CAGR: 27.26% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=1.44 | Chg7d=-0.002 | Chg30d=-0.049 | Revisions Net=-6 | Analysts=12
EPS current Year (2026-12-31): EPS=6.46 | Chg7d=-0.013 | Chg30d=-0.113 | Revisions Net=-4 | Growth EPS=+35.7% | Growth Revenue=+26.7%
EPS next Year (2027-12-31): EPS=7.77 | Chg7d=-0.036 | Chg30d=-0.030 | Revisions Net=-1 | Growth EPS=+20.2% | Growth Revenue=+17.3%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.5% (Discount Rate 12.0% - Earnings Yield 1.5%)
[Growth] Growth Spread = +10.6% (Analyst 21.1% - Implied 10.5%)
P/E Forward = 17.301
P/S = 6.5888
P/B = 8.2893
P/EG = 0.816
Revenue TTM = 5.86b USD
EBIT TTM = 1.80b USD
EBITDA TTM = 2.18b USD
Long Term Debt = 11.26b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.49b USD (from shortTermDebt, last quarter)
Debt = 14.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.41b USD (from netDebt column, last quarter)
Enterprise Value = 50.32b USD (36.91b + Debt 14.91b - CCE 1.50b)
Interest Coverage Ratio = 2.35 (Ebit TTM 1.80b / Interest Expense TTM 767.5m)
EV/FCF = 32.58x (Enterprise Value 50.32b / FCF TTM 1.54b)
FCF Yield = 3.07% (FCF TTM 1.54b / Enterprise Value 50.32b)
FCF Margin = 26.34% (FCF TTM 1.54b / Revenue TTM 5.86b)
Net Margin = 9.00% (Net Income TTM 527.4m / Revenue TTM 5.86b)
Gross Margin = 58.32% ((Revenue TTM 5.86b - Cost of Revenue TTM 2.44b) / Revenue TTM)
Gross Margin QoQ = 72.65% (prev 60.19%)
Tobins Q-Ratio = 1.74 (Enterprise Value 50.32b / Total Assets 28.99b)
Interest Expense / Debt = 1.25% (Interest Expense 186.1m / Debt 14.91b)
Taxrate = 3.94% (8.15m / 206.6m)
NOPAT = 1.73b (EBIT 1.80b * (1 - 3.94%))
Current Ratio = 2.24 (Total Current Assets 3.35b / Total Current Liabilities 1.49b)
Debt / Equity = 3.49 (Debt 14.91b / totalStockholderEquity, last quarter 4.28b)
Debt / EBITDA = 6.14 (Net Debt 13.41b / EBITDA 2.18b)
Debt / FCF = 8.68 (Net Debt 13.41b / FCF TTM 1.54b)
Total Stockholder Equity = 4.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.96% (Net Income 527.4m / Total Assets 28.99b)
RoE = 12.01% (Net Income TTM 527.4m / Total Stockholder Equity 4.39b)
RoCE = 11.51% (EBIT 1.80b / Capital Employed (Equity 4.39b + L.T.Debt 11.26b))
RoIC = 11.19% (NOPAT 1.73b / Invested Capital 15.47b)
WACC = 8.88% (E(36.91b)/V(51.82b) * Re(11.98%) + D(14.91b)/V(51.82b) * Rd(1.25%) * (1-Tc(0.04)))
Discount Rate = 11.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.95%
[DCF] Terminal Value 66.34% ; FCFF base≈2.01b ; Y1≈1.32b ; Y5≈601.0m
[DCF] Fair Price = N/A (negative equity: EV 10.19b - Net Debt 13.41b = -3.22b; debt exceeds intrinsic value)
EPS Correlation: 74.07 | EPS CAGR: 23.86% | SUE: -2.74 | # QB: 0
Revenue Correlation: 80.65 | Revenue CAGR: 27.26% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=1.44 | Chg7d=-0.002 | Chg30d=-0.049 | Revisions Net=-6 | Analysts=12
EPS current Year (2026-12-31): EPS=6.46 | Chg7d=-0.013 | Chg30d=-0.113 | Revisions Net=-4 | Growth EPS=+35.7% | Growth Revenue=+26.7%
EPS next Year (2027-12-31): EPS=7.77 | Chg7d=-0.036 | Chg30d=-0.030 | Revisions Net=-1 | Growth EPS=+20.2% | Growth Revenue=+17.3%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.5% (Discount Rate 12.0% - Earnings Yield 1.5%)
[Growth] Growth Spread = +10.6% (Analyst 21.1% - Implied 10.5%)